Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 2/20 | 0.50 |
| ▸ | BLM | P54132 | 1/20 | 0.41 |
| ▸ | KDM1A | O60341 | 1/20 | 0.40 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | KDM4C | Q9H3R0 | 2/20 | 0.37 |
| ▸ | KDM4A | O75164 | 1/20 | 0.37 |
| ▸ | PHF8 | Q9UPP1 | 1/20 | 0.37 |
| ▸ | KDM2A | Q9Y2K7 | 1/20 | 0.37 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.35 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.35 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.34 |
| ▸ | ENPEP | Q07075 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5613242 | 0.95 | CA1 (0.48) | CA1BLMKDM1APTPN1LMNA | |
| SCHEMBL10335747 | 0.92 | CA1 (0.48) | CA1BLMKDM1APTPN1LMNA | |
| SCHEMBL110531 | 0.89 | CA1 (0.60) | CA1BLMTRPA1 | |
| SCHEMBL4575366 | 0.86 | KDM4C (0.47) | CA1BLMKDM1ALMNAKDM4C | |
| SCHEMBL14350722 | 0.86 | CA1 (0.57) | CA1BLMTRPA1 | |
| SCHEMBL2531343 | 0.85 | CA1 (0.41) | CA1BLMKDM1APTPN1LMNA | |
| SCHEMBL2533370 | 0.85 | CA1 (0.41) | CA1BLMKDM1APTPN1LMNA | |
| SCHEMBL2533251 | 0.85 | CA1 (0.46) | CA1BLMKDM4CKDM4APHF8 | |
| SCHEMBL14342419 | 0.85 | MAPT (0.46) | CA1BLMKDM1AMAPTKMT2A | |
| SCHEMBL2533371 | 0.85 | CA1 (0.41) | CA1BLMKDM1APTPN1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 133 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2463374-A2 | Isolated alcohol dehydrogenase enzymes and uses thereof | Bio Architecture Lab, Inc. (US) | 2012-06-13 | — | — | EP | claimed |
| EP-2195440-A2 | BIOFUEL PRODUCTION | Bio Architecture Lab, Inc. (US) | 2010-06-16 | — | — | EP | claimed |
| US-20090155873-A1 | BIOFUEL PRODUCTION | BIO ARCHITECTURE LAB, INC. (US) | 2009-06-18 | — | — | US | claimed |
| US-20090139134-A1 | BIOFUEL PRODUCTION | BIO ARCHITECTURE LAB, INC. (US) | 2009-06-04 | — | — | US | claimed |
| WO-2009046370-A2 | BIOFUEL PRODUCTION | BIO ARCHITECTURE LAB, INC. (US) | 2009-04-09 | — | — | WO | claimed |
| WO-2009046375-A2 | BIOFUEL PRODUCTION | BIO ARCHITECTURE LAB, INC. (US) | 2009-04-09 | — | — | WO | claimed |
| US-20250339817-A1 | A PROCESS FOR THE NITRIC OXIDE ABATEMENT THROUGH BIOLOGICAL TREATMENTS | FUND EURECAT (ES) | 2025-11-06 | — | — | US | disclosed |
| EP-3230463-B2 | RAPID PRETREATMENT | APALTA PATENTS OUE (EE) | 2025-07-16 | — | — | EP | disclosed |
| US-20240425893-A1 | RAPID PRETREATMENT | Apalta Patents OÜ (EE) | 2024-12-26 | — | — | US | disclosed |
| US-12054761-B2 | Rapid pretreatment | Apalta Patents OÜ (EE) | 2024-08-06 | — | — | US | disclosed |
| US-11821047-B2 | High pressure zone formation for pretreatment | Apalta Patent OÜ (EE) | 2023-11-21 | — | — | US | disclosed |
| US-20230295678-A1 | RAPID PRETREATMENT | Apalta Patents OÜ (EE) | 2023-09-21 | — | — | US | disclosed |
| EP-4098750-A1 | RAPID PRETREATMENT | Sweetwater Energy, Inc. (US) | 2022-12-07 | — | — | EP | disclosed |
| US-6447557-B1 | HYDROCARBON OXYENATE WHICH IS SATURATED, ALIPHATIC MONOHYDRIC ALCOHOL, MONO- OR POLY-KETONE OR KETO-MONOHYDRIC ALIPHATIC ALCOHOL; ULTRA-LOW SULPHUR FUEL WITH REDUCED PARTICULATE EMISSIONS OVER A BROAD RANGE OF VEHICLES AND DRIVING CYCLES | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY | 2002-09-10 | — | — | US | disclosed |
| US-20020108299-A1 | Diesel fuel composition | EXXONMOBIL RESEARCH & ENGINEERING COMPANY | 2002-08-15 | — | — | US | disclosed |
| US-20020104256-A1 | Diesel fuel composition | EXXONMOBIL RESEARCH & ENGINEERING COMPANY | 2002-08-08 | — | — | US | disclosed |
| US-20020000063-A1 | Diesel fuel composition | EXXONMOBIL RESEARCH & ENGINEERING COMPANY | 2002-01-03 | — | — | US | disclosed |
| WO-2001046349-A1 | DIESEL FUEL COMPOSITION | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) | 2001-06-28 | — | — | WO | disclosed |
| WO-2001046348-A1 | DIESEL FUEL COMPOSITION | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) | 2001-06-28 | — | — | WO | disclosed |
| WO-2001046346-A1 | DIESEL FUEL COMPOSITION | EXXONMOBIL RESEARCH ENGINEERING COMPANY (US) | 2001-06-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090139134-A1 | BIOFUEL PRODUCTION | MGAM, DCXR, MANBA | CA1 2232/4885BLM 1093/4885KDM1A 3532/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.